Antibe Therapeutics to file application for initial order under CCAA
PremiumThe FlyAntibe Therapeutics to file application for initial order under CCAA
7M ago
Antibe Therapeutics Faces FDA Hold and Legal Challenges
Premium
Company Announcements
Antibe Therapeutics Faces FDA Hold and Legal Challenges
8M ago
Antibe Therapeutics Showcases Non-Opioid Pain Drug
Premium
Company Announcements
Antibe Therapeutics Showcases Non-Opioid Pain Drug
8M ago
Antibe Therapeutics price target lowered to C$0.50 from C$0.70 at Canaccord
PremiumThe FlyAntibe Therapeutics price target lowered to C$0.50 from C$0.70 at Canaccord
2y ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100